Systemic lupus erythematosus in pregnancy: Maternal and fetal outcomes and management strategies (Review)
Medicine International · 06.05.2026 · 6 (4) · 1-11
DOI: 10.3892/mi.2026.319 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medicine International, online erschienen am 06.05.2026. Verfasst von Isra Omar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, College of Medicine, Almaarefa University, Riyadh 11597, Kingdom of Saudi Arabia. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Systemic lupus erythematosus (SlE) is a chronic, multisystem, autoimmune disease that predominantly affects women during their reproductive years.Pregnancy in women with SlE is no longer considered uniformly prohibitive; however, it remains a high-risk clinical scenario due to maternal disease activity, lupus nephritis, antiphospholipid antibodies, chronic organ damage, and treatment-related factors that can adversely affect both maternal and fetal outcomes.Current evidence indicates that the risk of flare is highest in women who conceive with an active disease, discontinue effective therapy, or have a history of major organ involvement.at the same time, pregnancy introduces diagnostic complexity due to physiological gestational changes which may mimic lupus activity, particularly in hematological, renal and vascular domains.Maternal complications include preeclampsia, thromboembolism, infection, lupus nephritis exacerbation and postpartum flare, whereas fetal complications include miscarriage, fetal growth restriction, prematurity, neonatal lupus and congenital heart block in anti-ro/SSa-or anti-la/SSB-positive pregnancies.optimal management begins prior to conception and requires multidisciplinary care, risk stratification, medication optimization and structured maternal-fetal surveillance throughout pregnancy and the puerperium.the present narrative review summarizes contemporary evidence on the immunopathogenesis, preconception assessment, maternal and fetal risks, and therapeutic management of SlE in pregnancy, with an emphasis on clinically applicable strategies that improve patient outcomzes.Contents 1. Introduction 2. Pathogenesis of SlE 3. Effects of pregnancy on SlE 4. Pre-pregnancy counseling and considerations 5. Pre-pregnancy analyses in patients with SlE 6. Contraceptives in patients with SlE 7. Infertility in patients with SlE 8. Effects of SlE on pregnancy 9. Maternal complications associated with SlE 10.Placental disease in pregnancy in women with SlE and fetal complications of SlE 11.Puerperium 12. Medications for SlE during pregnancy 13.Biologics and emerging therapies 14.Conclusion
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Medicine, College of Medicine, Almaarefa University, Riyadh 11597, Kingdom of Saudi Arabia.
- Department of Internal Medicine, College of Medicine, University of Medical Sciences and Technology, Kigali 250, Rwanda.
- Royal College of Physicians of Ireland, Dublin 2, D02 E434, Ireland.
- TeleGeriatric Michigan State University Fellowship Program, Michigan State University, East Lansing, MI 48824, USA.
Zitieren
APA
Omar, I., Alakhras, A., Ahmad, M., & Mutwali, S. (2026). Systemic lupus erythematosus in pregnancy: Maternal and fetal outcomes and management strategies (Review). Medicine International, 6(4), 1-11. https://doi.org/10.3892/mi.2026.319
Vancouver
Omar I, Alakhras A, Ahmad M, Mutwali S. Systemic lupus erythematosus in pregnancy: Maternal and fetal outcomes and management strategies (Review). Medicine International. 2026;6(4):1-11. doi:10.3892/mi.2026.319
BibTeX
@article{Omar2026,
author = {Omar, Isra and Alakhras, Ahmed and Ahmad, Mona and Mutwali, Samahir},
title = {Systemic lupus erythematosus in pregnancy: Maternal and fetal outcomes and management strategies (Review)},
journal = {Medicine International},
year = {2026},
volume = {6},
number = {4},
pages = {1--11},
doi = {10.3892/mi.2026.319}
}
EUVIMED